Literature DB >> 29404848

Eliminating Regurgitation Reduces Fibrotic Remodeling of Functional Mitral Regurgitation Conditioned Valves.

Patrick S Connell1,2, Dragoslava P Vekilov1, Christine M Diaz1, Seulgi E Kim1, K Jane Grande-Allen3.   

Abstract

Functional mitral regurgitation (FMR) is an insidious and poorly understood condition affecting patients with myocardial disease. While current treatments reduce regurgitation, their ability to reverse mitral valve pathology is unclear. We utilized a pseudo-physiological flow loop to study how repair impacted valve composition. Porcine mitral valves were cultured in control geometry (native papillary muscle position and annular area) or high-tension FMR geometry (5 mm apical and 5 mm lateral displacement of papillary muscles, 65% increased annular area) for 2 weeks. To mimic repair, a reversal condition was created by returning one-week FMR conditioned valves to a non-regurgitant geometry and culturing for 1 week. Valve composition and material properties were analyzed. After two-week culture, FMR conditioned tissues were stiffer and stronger than control and underwent extensive fibrotic remodeling, with increased prolyl-4-hydroxylase, lysyl oxidase, matrix metalloproteinase-1, and decorin. The reversal condition displayed a heterogeneous, leaflet- and orientation-dependent response. Reversal-conditioned anterior leaflets and circumferential tissue sections continued to have significant fibrotic remodeling compared to control, whereas reversal-conditioned posterior leaflets, chordae tendineae, and radial tissue sections had significantly decreased remodeling compared to FMR-conditioned tissues. These findings suggest current repairs only partially reverse pathology, underscoring the need for innovation in the treatment of FMR.

Entities:  

Keywords:  Functional mitral regurgitation; Mitral valve repair; Organ culture

Mesh:

Year:  2018        PMID: 29404848      PMCID: PMC5897174          DOI: 10.1007/s10439-018-1987-9

Source DB:  PubMed          Journal:  Ann Biomed Eng        ISSN: 0090-6964            Impact factor:   3.934


  34 in total

1.  A new method of estimating gauge length for porcine aortic valve test specimens.

Authors:  Evelyn O Carew; Ivan Vesely
Journal:  J Biomech       Date:  2003-07       Impact factor: 2.712

2.  Integrated mechanism for functional mitral regurgitation: leaflet restriction versus coapting force: in vitro studies.

Authors:  S He; A A Fontaine; E Schwammenthal; A P Yoganathan; R A Levine
Journal:  Circulation       Date:  1997-09-16       Impact factor: 29.690

3.  Mitral valve stiffening in end-stage heart failure: evidence of an organic contribution to functional mitral regurgitation.

Authors:  K Jane Grande-Allen; J Edward Barber; Katrina M Klatka; Penny L Houghtaling; Ivan Vesely; Christine S Moravec; Patrick M McCarthy
Journal:  J Thorac Cardiovasc Surg       Date:  2005-09       Impact factor: 5.209

4.  Coapsys mitral annuloplasty for chronic functional ischemic mitral regurgitation: 1-year results.

Authors:  Yugal K Mishra; Sanjay Mittal; Pravesh Jaguri; Naresh Trehan
Journal:  Ann Thorac Surg       Date:  2006-01       Impact factor: 4.330

5.  Age-related changes in aortic valve hemostatic protein regulation.

Authors:  Liezl R Balaoing; Allison D Post; Huiwen Liu; Kyung Taeck Minn; K Jane Grande-Allen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-10-31       Impact factor: 8.311

6.  Independent prognostic value of functional mitral regurgitation in patients with heart failure. A quantitative analysis of 1256 patients with ischaemic and non-ischaemic dilated cardiomyopathy.

Authors:  Andrea Rossi; Frank L Dini; Pompilio Faggiano; Eustachio Agricola; Mariantonietta Cicoira; Silvia Frattini; Anca Simioniuc; Mariangela Gullace; Stefano Ghio; Maurice Enriquez-Sarano; Pier Luigi Temporelli
Journal:  Heart       Date:  2011-07-31       Impact factor: 5.994

7.  Differential impact of mechanical unloading on structural and nonstructural components of the extracellular matrix in advanced human heart failure.

Authors:  Siva S V P Sakamuri; Abhijit Takawale; Ratnadeep Basu; Paul W M Fedak; Darren Freed; Consolato Sergi; Gavin Y Oudit; Zamaneh Kassiri
Journal:  Transl Res       Date:  2016-02-23       Impact factor: 7.012

8.  Apparently normal mitral valves in patients with heart failure demonstrate biochemical and structural derangements: an extracellular matrix and echocardiographic study.

Authors:  K Jane Grande-Allen; Allen G Borowski; Richard W Troughton; Penny L Houghtaling; Nicholas R Dipaola; Christine S Moravec; Ivan Vesely; Brian P Griffin
Journal:  J Am Coll Cardiol       Date:  2005-01-04       Impact factor: 24.094

9.  Left ventricular reverse remodeling with a continuous flow left ventricular assist device measured by left ventricular end-diastolic dimensions and severity of mitral regurgitation.

Authors:  Jeffrey A Morgan; Robert J Brewer; Hassan W Nemeh; Raghav Murthy; Celeste T Williams; David E Lanfear; Cristina Tita; Gaetano Paone
Journal:  ASAIO J       Date:  2012 Nov-Dec       Impact factor: 2.872

10.  Effects of a saddle shaped annulus on mitral valve function and chordal force distribution: an in vitro study.

Authors:  Jorge Hernan Jimenez; Dennis Dam Soerensen; Zhaoming He; Shengqiu He; Ajit P Yoganathan
Journal:  Ann Biomed Eng       Date:  2003-11       Impact factor: 3.934

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.